Seres Therapeutics, Inc. - COMMON STOCK (MCRB)

CUSIP: 81750R102

Q3 2020 13F Holders as of 30 Sep 2020

Holder snapshot 7 signals
Share change
+14,316,996
Put/Call ratio
21%
SEC-reported price per share
$28.31
Number of holders
111
Value change
+$414,565,041
Number of buys
75
Open additional details 1 more signal available
Number of sells
42
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
170,403,883

Security key

81750R102

Report period

Q3 2020

Institutions

111

Top holders

10

Ownership snapshot

Top reported holders of MCRB - Seres Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Flagship Pioneering, LLC
Disclosed value leader
Flagship Pioneering, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F Highest disclosed value: $102,681,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Flagship Pioneering, LLC has the largest disclosed position value at $102.68M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Flagship Pioneering, LLC's linked filing trail.
Disclosed position value Top 5
Flagship Pioneering, LLC $102.68M
ARK Investment Management LLC $59.4M
Sumitomo Mitsui Trust Group, Inc. $35.22M
Amova Asset Management Americas, ... $34.78M
FMR LLC $27.33M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Flagship Pioneering, LLC
13F
Company
13F
—
denominator unverified
$102,681,000
21,571,764 shares
— 30 Jun 2020
ARK Investment Management LLC
13F
Company
13F
—
denominator unverified
$59,400,000
12,478,934 shares
— 30 Jun 2020
Sumitomo Mitsui Trust Group, Inc.
13F
Company
13F
—
denominator unverified
$35,225,000
7,400,245 shares
— 30 Jun 2020
Amova Asset Management Americas, Inc.
13F
Company
13F
—
denominator unverified
$34,781,000
7,400,245 shares
— 30 Jun 2020
FMR LLC
13F
Company
13F
—
denominator unverified
$27,332,000
5,742,076 shares
— 30 Jun 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$21,579,000
4,533,288 shares
— 30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
111
Shares
85,851,784
Rows available
111
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q3 2020 holders
111
Holder diff
110
Investor Q3 2025 Shares Q3 2020 Shares Share Diff Share Chg % Q3 2025 value Q3 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .